Literature DB >> 20864683

Role of cystatin C in neuroprotection and its therapeutic implications.

Luciano D'Adamio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20864683      PMCID： PMC2966774          DOI： 10.2353/ajpath.2010.100829

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  19 in total

Review 1.  Lysosomal cysteine proteases: more than scavengers.

Authors:  B Turk; D Turk; V Turk
Journal:  Biochim Biophys Acta       Date:  2000-03-07

2.  Cystatin C induces neuronal cell death in vivo.

Authors:  Atsushi Nagai; Jae K Ryu; Shotai Kobayash; Seung U Kim
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

3.  Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease.

Authors:  Patrick Shannon; Len A Pennacchio; Megan K Houseweart; Berge A Minassian; Richard M Myers
Journal:  J Neuropathol Exp Neurol       Date:  2002-12       Impact factor: 3.685

4.  Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes.

Authors:  K Lieuallen; L A Pennacchio; M Park; R M Myers; G G Lennon
Journal:  Hum Mol Genet       Date:  2001-09-01       Impact factor: 6.150

5.  Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1.

Authors:  R G Lafrenière; D L Rochefort; N Chrétien; J M Rommens; J I Cochius; R Kälviäinen; U Nousiainen; G Patry; K Farrell; B Söderfeldt; A Federico; B R Hale; O H Cossio; T Sørensen; M A Pouliot; T Kmiec; P Uldall; J Janszky; M R Pranzatelli; F Andermann; E Andermann; G A Rouleau
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

6.  Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.

Authors:  Riitta Rinne; Pekka Saukko; Mikko Järvinen; Anna-Elina Lehesjoki
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

7.  Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy.

Authors:  M D Lalioti; H S Scott; C Buresi; C Rossier; A Bottani; M A Morris; A Malafosse; S E Antonarakis
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

8.  Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1).

Authors:  Megan K Houseweart; Len A Pennacchio; Alex Vilaythong; Christoph Peters; Jeffrey L Noebels; Richard M Myers
Journal:  J Neurobiol       Date:  2003-09-15

9.  Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.

Authors:  L A Pennacchio; D M Bouley; K M Higgins; M P Scott; J L Noebels; R M Myers
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

10.  Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)

Authors:  L A Pennacchio; A E Lehesjoki; N E Stone; V L Willour; K Virtaneva; J Miao; E D'Amato; L Ramirez; M Faham; M Koskiniemi; J A Warrington; R Norio; A de la Chapelle; D R Cox; R M Myers
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728
View more
  6 in total

Review 1.  Microfluidic systems for stem cell-based neural tissue engineering.

Authors:  Mahdi Karimi; Sajad Bahrami; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Amirala Bakhshian Nik; Amir R Aref; Mohsen Akbari; Michael R Hamblin
Journal:  Lab Chip       Date:  2016-07-05       Impact factor: 6.799

Review 2.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

3.  Association of acute kidney disease with the prognosis of ischemic stroke in the Third China National Stroke Registry.

Authors:  Yilun Zhou; Dongxue Wang; Hao Li; Yuesong Pan; Xianglong Xiang; Yu Wu; Xuewei Xie; Xianwei Wang; Yang Luo; Xia Meng; Jinxi Lin; Hong Wang; Yong Huo; Kunihiro Matsushita; Jing Chen; Fan Fan Hou; Yongjun Wang
Journal:  BMC Nephrol       Date:  2022-05-18       Impact factor: 2.388

4.  Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome?

Authors:  Fábio G Teixeira; Krishna M Panchalingam; Sandra Isabel Anjo; Bruno Manadas; Ricardo Pereira; Nuno Sousa; António J Salgado; Leo A Behie
Journal:  Stem Cell Res Ther       Date:  2015-07-24       Impact factor: 6.832

5.  Modulation of the Mesenchymal Stem Cell Secretome Using Computer-Controlled Bioreactors: Impact on Neuronal Cell Proliferation, Survival and Differentiation.

Authors:  Fábio G Teixeira; Krishna M Panchalingam; Rita Assunção-Silva; Sofia C Serra; Bárbara Mendes-Pinheiro; Patrícia Patrício; Sunghoon Jung; Sandra I Anjo; Bruno Manadas; Luísa Pinto; Nuno Sousa; Leo A Behie; António J Salgado
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

6.  Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.

Authors:  Fábio G Teixeira; Miguel M Carvalho; Krishna M Panchalingam; Ana J Rodrigues; Bárbara Mendes-Pinheiro; Sandra Anjo; Bruno Manadas; Leo A Behie; Nuno Sousa; António J Salgado
Journal:  Stem Cells Transl Med       Date:  2016-09-22       Impact factor: 6.940
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.